CD163 and cancer: As the C1QA-C expression in cancers was mainly detected in CD68+CD163+ macrophages, the synthesis of complement C1q components analysed at the bulk RNA level can potentially be used to estimate the amount of pro-tumoural CD68+CD163+-like macrophages.